Edition:
United States

Palatin Technologies Inc (PTN.A)

PTN.A on American Stock Exchange

0.63USD
18 Sep 2017
Change (% chg)

$-0.02 (-3.08%)
Prev Close
$0.65
Open
$0.63
Day's High
$0.63
Day's Low
$0.62
Volume
477,929
Avg. Vol
139,975
52-wk High
$0.89
52-wk Low
$0.29

Chart for

About

Palatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and... (more)

Overall

Beta: 1.50
Market Cap(Mil.): $96.27
Shares Outstanding(Mil.): 152.80
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 79.97 16.21
EPS (TTM): -- -- --
ROI: -- 3.01 14.56
ROE: -- 4.79 13.83

BRIEF-Palatin Technologies signs agreement with Fosun Pharma

* Palatin Technologies announces signing of licensing agreement with Fosun Pharma rights to bremelanotide in China and other selected territories

Sep 06 2017

Earnings vs. Estimates